期刊文献+

半乳糖凝集素-3、可溶性基质溶素-2检测对心力衰竭诊断的相关性研究 被引量:24

Correlation Study of Galectin-3 and Soluble ST2 Levels in Heart Failure Diagnosis
下载PDF
导出
摘要 目的:探讨半乳糖凝集素-3和可溶性基质溶素-2(ST2)与慢性心力衰竭分级、传统心力衰竭指标的相关性。方法:选择2014-02至2015-10间在我院心血管内科就诊的慢性心力衰竭患者(慢性心力衰竭组)142例和健康体检人群(正常对照组)85例。按纽约心脏协会(NYHA)心功能分级标准将患者分为Ⅱ级、Ⅲ级、Ⅳ级。入院后完善N末端B型利钠肽原(NT-pro BNP)、高敏C反应蛋白(hs-CRP)、超声形态学等检查,并采用酶联免疫吸附法检测半乳糖凝集素-3、可溶性ST2的表达水平。结果:心力衰竭NYHA心功能Ⅲ级、Ⅳ级患者半乳糖凝集素-3、可溶性ST2明显升高。半乳糖凝集素-3、可溶性ST2与hs-CRP、NT-pro BNP呈正相关,与左心室射血分数呈负相关;可溶性ST2与左心室舒张末期内径(LVEDD)也呈正相关。Logistic分析显示,半乳糖凝集素-3和可溶性ST2与心力衰竭患者近期死亡存在相关性(P<0.05)。半乳糖凝集素-3、可溶性ST2诊断心力衰竭的受试者工作特征曲线(ROC曲线)下面积分别为0.738和0.771,差异有统计学意义(P<0.01)。结论:半乳糖凝集素-3、可溶性ST2与传统心力衰竭指标具有相关性,可用于慢性心力衰竭的诊断。 Objective: To study the correlations between galectin-3, soluble ST2 (sST2) levels and chronic heart failure (CHF) classiifcation, traditional HF indicator and short-term death in relevant patients. Methods: This research included 2 groups: CHF group, containing 142 relevant patients treated in our hospital from 2014-02 to 2015-10 and Control group, containing 85 normal subjects from physical examination at the same period of time. Based on NYHA criterion, the patients were classiifed in NYHA grade II, III and IV respectively. Blood levels of N-terminal brain natriuretic peptide (NT-ProBNP), high-sensitivity C reactive protein (hs-CRP) and ultrasonic morphology were examined upon admission; protein expressions of galectin-3 and sST2 were assessed by ELISA. Results: The patients with NYHA grade III and IV had increased levels of galectin-3 and soluble sST2; galectin-3, sST2 were positively related to NT-ProBNP, hs-CRP and LVEDD, while negatively related to LVEF. Logistic regression analysis indicated that galectin-3 and sST2 were related to short-term death in CHF patients,P〈0.05. Area under ROC curve of galectin-3 and sST2 for diagnosing CHF were 0.738 and 0.771,P〈0.01. Conclusion: Galectin-3 and sST2 levels were related to traditional HF indicator and could be used for CHF diagnosis in relevant&amp;nbsp;patients.
作者 徐晓晓 贾如意 王涛 刘强 甄臻 XU Xiao-xiao JIA Ru-yi WANG Tao LIU Qiang ZHEN Zhen(Department of Cardiology, The Fourth People's Hospital of Jinan, Taishan Medical College, Jinan (250031), Shandong, China)
出处 《中国循环杂志》 CSCD 北大核心 2016年第9期866-869,共4页 Chinese Circulation Journal
基金 济南市科技发展计划(200905036 201201051)
关键词 心力衰竭 半乳糖凝集素-3 可溶性基质溶素-2 N末端B型利钠肽原 诊断 Heart failure N-terminal brain natriuretic peptide Diagnosis
  • 相关文献

参考文献13

  • 1Shah AS, Langrish JP, Nair H, et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet, 2013, 382: 1039-1048.
  • 2梅松涛.半乳糖凝集素3对慢性心力衰竭的诊断价值[J].南京医科大学学报(自然科学版),2015,35(9):1238-1241. 被引量:11
  • 3Felker GM, Fiuzat M, Shaw LK, et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail, 2012, 5: 72-78.
  • 4Laneellotti P, Dulgheru R, Magne J, et al. Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis. PLoS One, 2015, 10: e0138940.
  • 5Duan F, Qi Z, Liu S, et al. Effectiveness of bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: an echoeardiographie study of left ventricular remodeling. Med Uhrason, 2015 , 17: 160- 166.
  • 6Ahuja K, Crooke GA, Grossi EA, et al. Reversing left ventricular remodeling in chronic heart failure: surgical approaches. Cardiol Rev, 2007, 15: 184-190.
  • 7Sun RR, Lu L, Liu M, et al. Biomarkers and heart disease. Eur Rev Med Pharmacol Sci, 2014, 18: 2927-2935.
  • 8秦月,仲琳,杨军.冠心病患者冠状动脉病变程度与半乳糖凝集素-3水平的相关性分析[J].中国循环杂志,2015,30(5):442-445. 被引量:13
  • 9de Boer RA, van Veldhuisen D J, Gansevoort RT, et aL The fibrosis marker galectin-3 and outcome in the general population. J Intern Med, 2012, 272: 55-64.
  • 10van der Velde AR, Lexis CP, Meijers WC, et al. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clin Chim Acta, 2016, 452: 50-57.

二级参考文献57

  • 1陈纯波,孙诚,吴粤.充血性心力衰竭患者血浆N-端脑利钠肽前体水平的变化[J].实用医学杂志,2005,21(11):1164-1165. 被引量:20
  • 2Sanada S,Hakuno D,Higgins LJ,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardio- protective signaling system[J]. Clin Invest, 2007,117 (6) : 1538-1549.
  • 3McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure:The framingham study[J]. N Engl J Med, 1971,285 (26) : 1441-1446.
  • 4Tschope C, Kasner M, Westermannd D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dys- function :Correlation with echocardiographic and invasive measurements[J]. Eur Heart J, 2005,26 (21 ) : 2277 -2284.
  • 5Mottram PM, Marwick TH. Assessment of diastolic func- tion:what the general cardiologist needs to know[J]. Heart, 2005,91 (5) : 681-695.
  • 6Grewal J ,Mckelvie R,Lonne, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008,10 (3) : 252-259.
  • 7Lee JH,Wang LC,Yu HH,et al. Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma[J]. Mediators Inflamm, 2010,20 ( 13 ) : 567-573.
  • 8Ali S,Huber M,Kollewe C,et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells[J]. Proc Natl Acad Sci USA, 2007. 104(47) :18660-18665.
  • 9Sanada S,Hakuno D,Higgins LJ,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardio protective signaling system[J]. J Clin Invest,2007,117 (6) : 1538-1549.
  • 10Bartunek J, Delrue L, Van Durme F, et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load[J]. J Am Coil Cardiol,2008, 52(25) :2166-2174.

共引文献55

同被引文献194

引证文献24

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部